Contrast agent for photoacoustic imaging
US-2015290345-A1 · Oct 15, 2015 · US
US10646596B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10646596-B2 |
| Application number | US-201615070405-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2016 |
| Priority date | Mar 23, 2015 |
| Publication date | May 12, 2020 |
| Grant date | May 12, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel near-infrared dye-bound transferrin exhibiting a high absorption coefficient in the near-infrared wavelength region, a high tumor accumulation property, a high tumor/blood ratio and a high imaging contrast, and a contrast agent for photoacoustic imaging, including the same are provided. A compound is provided in which transferrin and an organic dye having a specified structure that absorbs light in the near-infrared wavelength region are covalently bound.
Opening claim text (preview).
What is claimed is: 1. A contrast agent comprising a compound represented by formula (I-1): TF−(D)n (I-1), wherein, in the formula (I-1), TF represents transferrin, n is 4.8 to 7.0, and D represents formula (d5) or formula (d6): wherein, in the formulae (d5) and (d6), * represents a binding bond bound to the transferrin, and wherein, in the formula (d6), Y − represents a halogen ion or an organic acid ion. 2. A contrast agent comprising a compound represented by formula (I-1): TF−(D)n (I-1), wherein, in the formula (I-1), TF represents transferrin, D represents a near-infrared dye of formula (d5), and n is 4.8 to 7.0: wherein, in the formula (d5), * represents a binding bond bound to an amino group in the transferrin. 3. The contrast agent according to claim 1 , wherein the transferrin is any of human transferrin, a variant of human transferrin, a fragment of human transferrin, and a fragment of the variant of human transferrin. 4. The contrast agent according to claim 1 , further comprising a capturing molecule. 5. The contrast agent according to claim 1 , further comprising a dispersion medium, wherein the contrast agent is suitable for photoacoustic imaging. 6. The contrast agent according to claim 5 , further comprising an additive.
Peptides, proteins, polyamino acids · CPC title
characterised by the targeting agent or modifying agent linked to the acoustically-active agent · CPC title
Fluorescein, used in vivo · CPC title
Indocyanine green, i.e. ICG, cardiogreen · CPC title
Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.